chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning an unidentified male patient who was vaccinated with a dose of Hepatitis B vaccine. Subsequently, that same day he experienced muscle cramping, especially in his sides. Within a day he developed a pea sized nodule on his left arm biceps muscle A short time later he then noticed another nodule on his right elbow. He also complained of edema and ecchymosis on his arms. The physician confirmed some discoloration of the skin on the arms. A biopsy of the nodules was done by the physician and as of 10/04/00, results were still pending. Additional information has been requested.
Intermittent pain left side of head and down neck  Doc said no way to know if it is from vaccine and may just be a pinched nerve
Nausea; Vomiting; Headache; Fever; Body aches; Chills; Joint pain, hip pain; Spinal pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 15Sep2021 at 07:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ocrelizumab (OCREVUS) and fluvoxamine maleate (LUVOX); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on an unknown date in Aug2021 at 07:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient previously also received azithromycin (ZITHROMAX) and gadolinium (MANUFACTURER UNKNOWN) and experienced drug allergy. On 15Sep2021 at 15:00, the patient experienced nausea, vomiting, headache, fever, body aches, chills, joint pain, hip pain, spinal pain and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, headache, fever, body aches, chills, joint pain, hip pain, spinal pain and fatigue was recovered with sequelae (reported as recovered with lasting effects) on an unknown date in Sep2021.
Patient received Janssen COVID vaccine in our facility on 10/4/21.  She immediately developed left arm, left jaw, and neck numbness. She was monitored for 30 minutes with BP and pulse oximetry. All reactions resolved during that time.
Pt waiting in Observation had vaccine at 17:47 - 2nd dose -   18:00 c/o tingling around lips and then tongue swelling Had 50 mg of benadryl IM to left deltoid at 18:04   18:13 BP 108/80 HR 100 Pulse ox on RM air was 96%    18:15 HR 104 on monitor BP 110/80    18:21   Transported by Wheelchair to ED for further evaluation
Patient came in Health dept and stated she was there to get her 2 nd covid shot. Clerk did not check schedule for the day or she would have noticed this patient was not on the schedule for today.Patient completed paperwork and turned it into clerk who then pulled up record--and did not notice that pateints first covid shot was given on 03-22-2021 so it was really too soon to get the 2 nd shot( was actually due on 04-19-2021 and patient was on the schedule for that day also).Patient then went to nurse and nurse administered shot for 2 nd dose of Moderna. Patient left after observation time. This was not discovered until end of day when another nurse was checking through all the paperwork for the day and noticed that the second shot was given on day 17 after the first shot--is supposed to be given on day 28 after first vaccine.
booster; Pretty sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 Immunization; Bnt162b2 (DOSE 2, My daughter from her booster and her second shot was pretty sick for 2 or 3 days), for COVID-19 Immunization, reaction(s): "pretty sick". The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; ILLNESS (non-serious), outcome "recovered" (2021), described as "Pretty sick".  Additional information: The reporter stated that " I had the 2 first shots they were absolutely nothing, didn't even feel the prick. My daughter from her booster and her second shot was pretty sick for 2 or 3 days so I guess it effects everybody differently".   The lot number for bnt162b2 was not provided and will be requested during follow up.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a pharmacist concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 212A21A, and expiry: 21-DEC-2021) dose was not reported, administered on 22-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-DEC-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211250766.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 30-NOV-2015, the patient was vaccinated with improperly stored (exposed to the following temperatures and cumulative time frames colder than 36 F: In September of 2016, the coldest temperature was 34 F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34 F for 492.6 hours for a total of 839.9 hours (35 days); In November of 2015, the coldest temperature was 34 F for 192 hours, for a total of 1,031.3 hours (43 days)) VAQTA injection, 0.5 ml (lot # L023936, exp. date: 15-MAR-2017) (route and strength unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
mark on her arm/"divit" in her arm; mark on her arm/"divit" in her arm and pain/The pain is getting worse; Is an indentation, like a divet, in the arm at the injection site; arm pain; everything is tanning except for that spot on left arm; crying; This is a spontaneous report from a contactable consumer (patient).   A 59-years-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EL1284; Expiration Date: Apr2021), via an unspecified route of administration, administered in left arm on 27Jan2021 10:30 as 1st dose, single dose(at the age of 59-years-old) for COVID-19 immunization. The patient medical history and concomitant medications were not reported. No history previous immunizations, and vaccinations within 4weeks. The patient experienced mark on arm, is an indentation, like a divet, in the left arm at the injection site and reported the mark was for a week or two after; and had arm pain, this is the same arm where the pain is. Patient started to get tan and everything is tanning except for that spot on her left arm. The pain has been worse, It hurts her so bad she wakes up in pain crying. In her opinion, the divot looks like it is getting bigger. Patient reported she visited to emergency room or physician office, and also reported she had a bloodwork but that was after and in opposite arm, in the right arm not the left and mammogram done last month. Patient refused to take the second dose of vaccination. The outcome of events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Very big softball size redness, patient also has a knot located at the redness. Not hot to touch. Mom stated there was no fever
tiredness; This is a spontaneous report from contactable pharmacist via Pfizer sales representative. A 50-year-old patient of an unspecified gender received the first dose of bnt162b2 (BNT162B2; lot and expiry date was not reported) via an unspecified route of administration on an unspecified date at a single dose for immunization. Medical history was reported as none. The patient's concomitant medications were not reported. The patient experienced tiredness on an unspecified date following administration of bnt162b2 vaccine. Outcome of the event recovered on an unspecified date   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
3-17-21 6:30PM 'LT ARM FEELS COLD'.  LT ARM IS SLIGHTLY COOLER THAN RT ARM TO TOUCH.  GOOD CAP REFILL.  NO NEURO OR MOTOR DEFICIT. AMBULATORY TO EXIT WITHOUT ANY ACUTE DISTRESS. 3-19-21 8:50AM TC:  'LT ARM FEELS FINE NOW'.
Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Mild, Systemic: Shakiness-Medium, Systemic: Tachycardia-Mild, Additional Details: patient complained of dizziness, became tachycardic (130-145bpm) lost consciousness for 30 to 45 seconds, once in supine position became conscious, blood pressure measured x 3 (wnl) HR monitored x 15min (wnl).  pt obtained ride home with girlfriend. she will continue to monitor for next 24 hours.
Information has been received from a physician concerning a female retired volunteer who on 19-APR-2007 was vaccinated IM with a 0.65 ml dose of ZOSTAVAX (Lot#656606/0033U). On 18-JUN-2007, "three weeks after" vaccination, the patient developed a mild case of shingles. Unspecified medical attention was sought. At the time of this report the patient's status was unspecified. No further information was provided. there was no product quality complaint involved. Follow up information received from the nurse said that the patient has had 2 outbreaks of zoster on unknown dates since the vaccination on 19-APR-2007 (onset date of 18-JUN-2007 also provided). It was noted that a rash did not occur at the site of injection or elsewhere within 42 days of the vaccination. At the time of the outbreaks there was 1 lesion on the right gluteal region which was red with blisters and 2 smaller lesions lateral. There was an exposure to chickenpox or herpes zoster on 16-JUL-2007. There was no direct fluorescent antibody done, nor was a specimen collected for PCR. No photo was taken. Additional information received indicated that no additional information was available.
Patient received 2nd dose of covid vaccine and stated that fingers felt numb and tongue was slightly numb. After 20 minutes EMTs were called and patient was checked out clear and refused services
Patient took vaccine at 10am.  We asked Pt to stay in observation area for 30 min because of reaction to Penicillin and a flu shot 10 years ago.  At 10:04am patient complained about not being able to breathe.  We called 911 and We immediately gave patient a shot of Epi-pen and observed patient. We took patient's blood pressure as well. We stayed with patient and administered a second shot of Epi-pen as patient still could not breathe.  After second shot patient was able to breathe and was attended by EMT.
flu like symptoms after the second dose; This is a spontaneous report from a non-contactable physician. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot number and Expiration date: Not reported), via an unspecified route of administration on an unspecified date as 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced flu like symptoms after the second dose but simply rested on the couch watched some tv and was fine. The clinical outcome of flu like symptoms was unknown.  No follow-up attempts are possible. No further information is expected.
I noticed some hives on my arms, face, and chest area at around 3 or 4pm, and next day it was still present but a little red. It?s better but still here.
Rt thigh swollen, red area- 8x8 cm- with blistering.
Eczema, ankles, waist, back,neck,scalp. This was after 3rd covid 19 booster vaccine. No issues first2 vaccines. Have never had Eczema before
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 26-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterated that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State currently. It was reported that no adverse reactions were experienced by any patients.  No treatment medication was reported.
pt recvd vax; GBS;first numbness on 28nov95; hosp 29nov95; Plasmaphoresis; still in hosp as of 6dec95;
Patient received SHINGRIX dose 1 on 9/5/18 at 221P NDC # 58160081912 in left arm and states he had soreness from shot waited 3 weeks then got his flu vaccine. On 1/26/19 the pharmacy called to let him know his second dose of SHINGRIX was in and he was due for it. That's when he stated he is still having arm pain from his shot(s). He's not sure which one caused it. He thought pain after SHINGRIX was getting better but then after flu shot states it felt the same so he's not sure if it ever went away. It is now 4 months since both shots and he's stating he still has pain. He has an appointment with his PCP middle of Feb 2019 and he states he will report it to the doctor and see if the doctor still recommends that he get the second dose of SHINGRIX.
Malaise; shooting pain from the injection site to the side of her neck; shooting pain from the injection site to the side of her neck; difficulty sleeping; warm and tender at the site; This is a spontaneous report received from a contactable reporter (Pharmacist).  An 81-year-old female patient received pneumococcal 20- valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 20), on 13Jul2022 as dose number unknown, 0.5ml single (Lot number: FJ2604, Expiration Date: 30Jun2023) at the age of 81 years, in right arm for immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing). There were no concomitant medications. The following information was reported: MALAISE (non-serious) with onset 13Jul2022, outcome "not recovered"; INSOMNIA (non-serious) with onset 13Jul2022, outcome "not recovered", described as "difficulty sleeping"; VACCINATION SITE PAIN (non-serious), NECK PAIN (non-serious) all with onset 13Jul2022, outcome "not recovered" and all described as "shooting pain from the injection site to the side of her neck"; VACCINATION SITE WARMTH (non-serious) with onset 13Jul2022, outcome "not recovered", described as "warm and tender at the site". Additional information: The patient received the vaccine at about 12:00 on 13Jul2022 and the symptoms started in the afternoon at about 16:00pm or 17:00pm on 13Jul2022.  No follow-up attempts are needed. No further information is expected.
arm itching; sore arm; arm rash; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (sore arm), INJECTION SITE RASH (arm rash) and INJECTION SITE PRURITUS (arm itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (sore arm), INJECTION SITE RASH (arm rash) and INJECTION SITE PRURITUS (arm itching). At the time of the report, INJECTION SITE PAIN (sore arm), INJECTION SITE RASH (arm rash) and INJECTION SITE PRURITUS (arm itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details were not reported by the reporter.
Site became red, with "fever" and tender to touch.  Redness has spread down from deltoid area into bicep in an approximately 3" band to just above elbow.  Employee has been taking Motrin for fever and pain and she states that it is a "little better" than previous to 10/1/2010.
5x5 cm area of erythema, warmth, tenderness and induration following varicella vaccination to (L) deltoid. Dx: Cellulitis Tx: Keflex 500 mg BID x 10d
back pain that shifted positions and was then in the left neck, shoulder and arm regions; back pain that shifted positions and was then in the left neck, shoulder and arm regions; back pain that shifted positions and was then in the left neck, shoulder and arm regions; back pain that shifted positions and was then in the left neck, shoulder and arm regions; This is a spontaneous report from a contactable consumer (patient). This 35-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in the left arm on 28Jan2021 (at 35-years of age) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medications included testosterone cipionate, vortioxetine hydrobromide (TRINTELLIX) and propranolol, all from unknown dates for unknown indications. The patient previously received the first dose of BNT162B2 (lot number EK9231) on 06Jan2021 at 16:00 (at 35-years of age) for COVID-19 immunisation. The patient reported experiencing rapid onset of back pain that shifted positions and was then in the left neck, shoulder and arm regions on 04Feb2021 at 07:00, 7 days following the second shot. He reported he was referred by his primary care physician and physical therapist to a physiatrist specializing in spine/neck issues. It was unknown if treatment was received for the events. The clinical outcomes of back pain that shifted positions and was then in the left neck, shoulder and arm regions were not recovered. It was also reported that since vaccination, the patient had tested negative for COVID-19 via blood test on 15Feb2021.  No follow-up attempts are needed; information about lot number cannot be obtained.
p/vax pt exp muscle pain, swollen knee, fatigue & burning eyes;MD visit was required & was treated w/Ibuprofen & eyedrops;pt condition is ongoing;
p/vax major behavior changes 9/3-9/6/99;no fever, etc;temper tantrums, extreme, irritability;
this is about the lap=band - i had it filled jan 15th and this time its holding fluid but 3 previous times the saline fill dissipitated within 6 weeks - i had it checked and in 6 weeks it went from 3.2 to 2.6 - i could tell as i was able to eat more - i can see losing fluid in the band in 6 months but not 6 weeks - a test was done in jan and they said it wasn't leaking - so where did the fluid go - you begin to regain if that restriction isn't tight - these trips are costly - not less than $160 to fill - though my hospital plan picks this up - i complained to the company and they don't have an answer but the last fill is so far holding up and its 6 weeks - disregard 13 but i had to enter something to submit this
Pt. fell to ground, hit back of head, did no lose consciousness. Pt. remained in office, lying down -  B/P 100/70 for one hour.
Very nauseated for 3 days - couldn't bend over I was so sick to my stomach
This spontaneous report was received from a nurse refers to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On unspecified dates, the patients were in advertently vaccinated with improperly stored doses of M-M-R II (lot #, expiry date, dose, strength, vaccination site, route unspecified). No adverse effect were reported. Product quality complaint (PQC) was not involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Administered Pfizer Grey cap vial dose of 0.3 mL - should have been Orange Cap vial of 0.2mL for child's age
On 3/4/2021 received vaccine. On 3/10/2021 injection area started to itch. On 3/11/2021 noted red circle around injection site about two inches in diameter.  Area was hot to touch, itching, and swelling noted.  I applied Lidocream ointment which gave a little relief. Today 3/12/2021, area less red still some itching still some heat in area.
I was feeling really tired and congested. On November 30th I ended going to the hospital with chest pain and I had a pulmonary embolism. I was in the hospital until December for that through December 2nd but they never tested me for COVID-19. I ended up having shortness of breath, fever, congestion, and was not feeling well. I ended up going to an urgent care and tested positive for COVID-19. I have some lingering shortness of breath today but over all I have recovered from COVID-19.
10 days post immunization-2 raised dots on face-next day total body bumoy rash, diarrhea since 1-11-02. No treatment - advised desitin & oatmeal bath
Vaccine administered Left deltoid 2/23/06. Paralysis right side of mouth first noted by school nurse on 2/27. Patient developed classic Bell's Palsy. Referred seen 8/31/06 at facility 100% recovery. 03/23/07-records received-Bell's Palsy. PMH:Developmental delay, ataxic cerebral palsy.